Plasma proteomic profiling in hereditary breast cancer reveals a BRCA1-specific signature: Diagnostic and functional implications

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Scumaci, Domenica ^a   Tammè, Laura ^a   Fiumara, Claudia Vincenza ^a   Pappaianni, Giusi ^a   Concolino, Antonio ^a   Leone, Emanuela ^a   Faniello, Maria Concetta ^a   Quaresima, Barbara ^a   Ricevuto, Enrico ^b   Costanzo, Francesco Saverio ^a   Cuda, Giovanni ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; GELSOLIN; PLASMA PROTEIN; PROTEOME; SMALL INTERFERING RNA; BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; MESSENGER RNA;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FAMILIAL CANCER; GENE MUTATION; HEREDITARY BREAST CANCER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BLOOD LEVEL; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; STOP CODON; TANDEM MASS SPECTROMETRY; TUMOR SUPPRESSOR GENE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; BLOOD; BREAST TUMOR; FEMALE; GENETICS; METABOLISM; MUTATION;

BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; HUMANS; MUTATION; PROTEOME; RNA, MESSENGER;

EID: 84936885185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129762     Document Type: Article

References (46)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11[Internet]
2. Gruvberger-Saal SK, Cunliffe HE, Carr KM, Hedenfalk IA. Microarrays in breast cancer research and clinical practice-the future lies ahead. Endocr Relat Cancer. 2006 Dec; 13(4):1
3. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302:643-646. PMID: 14576434
4. Welcsh PL, Owens KN, King MC. Insights into the functions of BRCA1 and BRCA2. Trends Genet 2000; 16:69-74. PMID: 10652533
5. Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. The Role of BRCA1 in cellular responses to chemotherapy. J Natl Cancer Inst 2004; 96:1659-1668. PMID: 15547178
6. King MC. Insights into the functions of BRCA1 and BRCA2. Trends Genet 2000; 16:69-74. PMID: 10652533
7. Yu VPCC, Koehler M, Steinlein C, Schmid M, Hanakahi LA, Van Gool AJ, et al. Gross chromosomal rearrangements and genetic exchange between non homologous chromosomes following BRCA2 inactivation. Genes Dev 2000; 14:1400-6. PMID: 10837032
8. Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R, et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 1997; 57:1222-7. PMID: 9102202
9. Chung L, Baxter RC. Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays. Expert Rev Proteomics 2012; 16:599-614.
10. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007; 16:5287-5312.
11. Duffy MJ. Serum tumor markers in breast cancer: are they of clinical value? Clin Chem. 2006; 16:345-351.
12. Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature 2008; 16:571-579.
13. Wang H, Clouthier SG, Galchev V, Misek DE, Duffner U, Min CK, et al. Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol Cell Proteomics 2005 May; 4(5):618-25. Epub 2005 Feb 9. PMID: 15703445
14. Darde VM, Barderas MG, Vivanco F. Depletion of high-abundance proteins in plasma by immunoaffinity subtraction for two-dimensional difference gel electrophoresis analysis. Methods Mol Biol. 2007; 357:351-64. PMID: 17172701
15. Baudi F, Quaresima B, Grandinetti C, Cuda G, Faniello C, Tassone P, et al. Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer. Hum Mutat. 2001 Aug; 18(2):163-4. PMID: 11462242
16. Echan L.A., Tang H.Y., Ali-Khan N., Lee K., Speicher D.W. Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics. 2005. 5 (13):3292-303. PMID: 16052620
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7; 72:248-54. PMID: 942051
18. Cleveland DW, Fischer SG, Kirschner MW, Laemmli UK. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem. 1977 Feb 10; 252(3):1102-6. PMID: 320200
19. Weiss W, Gorg A. High-resolution two-dimensional electrophoresis. Methods Mol. Biol. 2009, 564, 13-32. doi: 10.1007/978-1-60761-157-8-2 PMID: 19544015
20. Seillier-Moiseiwitsch F: The Proteomics Protocols Handbook. 2005, 239-258.
21. Sinha P, Poland J, Schnolzer M, Rabilloud T. A new silver staining apparatus and procedure for matrix-assisted laser desorption/ionization-time of flight analysis of proteins after two-dimensional electrophoresis. Proteomics 2001, 1, 835-840 27. PMID: 11503208
22. Gharahdaghi F, Weinberg CR, Meagher DA, Imai BS, Mische SM. Mass spectrometry identification of proteins from silver stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 1999; 20, 601-605. PMID: 10217175
23. Di Domenico M, Scumaci D, Grasso S, Gaspari M, Curcio A, Oliva A, et al. Biomarker discovery by plasma proteomics in familial Brugada Syndrome. Front Biosci (Landmark Ed). 2013 Jan 1; 18:564-71. PMID: 23276942
24. Zivy M. Quantitative analysis of 2D gels. Methods Mol Biol. 2007; 355:175-94. PMID: 17093311
25. Hellman U, Wernsted C, Gonez J, Heldin CH. Improvement of an "In-Gel" digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. Anal. Biochem. 1995; 224, 451-455. PMID: 7710111
26. Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem. 2003; 75, 663-670. PMID: 12585499
27. Kra¨mer A, Green J, Pollard J, Tugendreich S. Causal Analysis Approaches in Ingenuity Pathway Analysis (IPA). Bioinformatics 2013 Dec 13. PMID: 24336805.
28. Choi S1, Lim JY, Kim Y, Song MJ, Jung WW, Seo JB, et al. Plasma proteomic analysis of patients infected with H1N1 influenza virus. Proteomics. 2014 Aug; 14(16):1933-42. doi: 10.1002/pmic.201400030 PMID: 24888898
29. Morelli M, Scumaci D, Di Cello A, Venturella R, Donato G, Faniello MC, et al. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes. Int J Gynecol Cancer. 2014 May; 24(4):649-58. doi: 10.1097/IGC.0000000000000102 PMID: 24614826
30. Rajan JV1, Wang M, Marquis ST, Chodosh LA. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci U S A. 1996 Nov 12; 93 (23):13078-83. PMID: 8917547
31. Marks JR, Huper G, Vaughn JP, Davis PL, Norris J, McDonnell DP, et al BRCA1 expression is not directly responsive to estrogen Jeffery R Marks Oncogene 02/1997; 14(1):115-21. PMID: 9010238
32. Bartz SR1, Zhang Z, Burchard J, Imakura M, Martin M, Palmieri A, et al. Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Mol. Cell. Biol. 2006, 26(24), 9377-86. PMID: 17000754
33. Faniello MC, Di Sanzo M, Quaresima B, Baudi F, Di Caro V, Cuda G, et al. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y. Int J Biochem Cell Biol. 2008; 40 (10):2110-9. doi: 10.1016/j.biocel.2008.02.010 PMID: 18372207
34. Mukhopadhyay A, Deplancke B, Walhout AJ, Tissenbaum HA. Chromatin immunoprecipitation (ChIP) coupled to detection by quantitative real-time PCR to study transcription factor binding to DNA in Caenorhabditis elegans. Nat Protoc. 2008; 3: 698-709. doi: 10.1038/nprot.2008.38 PMID: 18388953
35. Houvras Y, Benezra M, Zhang H, Manfredi JJ, Weber BL, Licht JD. BRCA1 physically and functionally interacts with ATF1. J Biol Chem. 2000 Nov 17; 275(46):36230-7. PMID: 10945975
36. Dong Y1, Asch HL, Ying A, Asch BB. Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells. Exp Cell Res. 2002 Jun 10; 276(2):328-36. PMID: 12027462
37. Veenstra TD1, Conrads TP, Hood BL, Avellino AM, Ellenbogen RG, Morrison RS. Biomarkers: mining the biofluid proteome. Mol Cell Proteomics. 2005 Apr; 4(4):409-18. PMID: 15684407
38. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001 Feb 22; 344(8):539-48. PMID: 11207349
39. Esteller M1, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 2000 Apr 5; 92 (7):564-9. PMID: 10749912
40. Winston JS1, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB. Downregulation of gelsolin correlates with the progression to breast carcinoma. Breast Cancer Res Treat. 2001 Jan; 65(1):11-21.). PMID: 11245335
41. Kusano H, Shimizu S, Koya RC, Fujita H, Kamada S, Kuzumaki N, et al. Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC. Oncogene 2000; 19: 4807-14. PMID: 11039896
42. Liu J, Liu YG, Huang R, Yao C, Li S, Yang W, et al. Concurrent downregulation of Egr-1 and gelsolin in the majority of human breast cancer cells. Cancer Genomics Proteomics 2007; 4:377-85. PMID: 18204200
43. Thor AD, Edgerton SM, Liu S, Moore DH II, Kwiatkowski DJ. Gelsolin as negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers. Clin Cancer Res 2001; 7:2415-24. PMID: 11489821
44. De Corte V, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J, Gettemans J. Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO J 2002; 21:6781-90., 26. PMID: 12485999
45. Chen P, Murphy-Ullrich JE, Wells A. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol 1996; 134:689-98. PMID: 8707848
46. Tanaka H, Shirkoohi R, Nakagawa K, Qiao H, Fujita H, Okada F, et al. siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells. Int J Cancer 2006; 118:1680-91. PMID: 16217750